Clinical Trial Update: Venetoclax Based Regimen for R/R T-ALL [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a venetoclax-based regimen for relapsed/refractory T-cell acute lymphoblastic leukemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• T-cell Acute Lymphoblastic Leukemia

Drugs mentioned

• Venetoclax (venetoclax)

Snippet

Sponsor: The First Affiliated Hospital of Soochow University | Conditions: Acute T-Lymphocytic Leukemia | Phase 2 | Status: COMPLETED